ACE2 overexpression and administration of exogenous Ang-(1–7) alleviated Ang II or diabetes-induced cardiac hypertrophy and fibrosis (Zhai et al., 2018; Dang et al., 2020). This evidence concerns the gene AGT and cardiac hypertrophy.